Cf6t3p3m7m2 hs1r8d8r2 zv7a2k1e10t2 pharmacological examination papers (answers) sector: name: one, single questions (2 in 2 per questions, 40 in all) 1 , first access to (c), legal qualification b, business licence c, drug operating licence d, health qualifications 2 , drug operating licences (d), drugs operating licences (d), 3 years b, 2 years c, 4 years d, 5 years d, 3 years , pharmaceutical enterprises buying medicines, needing and executing (b), validation of medicines and other markings; a, tracking system b, acquisition and inspection system c, certification system d, treatment and control system d 4
5. Which of the following treatments can be given to (c), (b), (b), (b), (b), (b), (b), (b), (b), (b), (b) and (c), (c), (c), (e) herpes, (c) and (c), (b), (b), (b), (b), (b), (b) and (c) and (c), (c), (b), (b), (c) and (c), (b), (c) and (c), (c) and (c), (c), (c) and (e), (c), (c) and (e), (d), (d, (d), (d), (d), (d), (d), (d), (x) and (x), (x) and (x) , (x) , (x) and (x) , (x) , (x) , (x) and (x) , (x) are all wrong for treatment of chronic ana
3, certification and marking (d) a, statement b, certificate c, label d, quality standard 9 is based on 2022 chinese pharmacy under the condition of storage at constant temperature at (d) a, 030 b, 025 c, 020 d, 1030 10, with the following reasonable combinations (d): a, a, amosilin + c, c, c, d, d, d, c, d, d, d, the drugs that are not anti-facting (d), a, b, c, d, d, c, c
A, o2 b, co2 c, humidity d, temperature 16, plasma packaging marked lot. No 2022102, exp. Date 10/1/202, p. 1, p. 3 (a): a, 20xx october 20b, 20xx october 2, 20xx d, 20xx, 12 october 20, 17
5 drugs subject to reduction due diligence (c, 20xx, 30 september a): a, c, l, c, e, d, s., 18, a, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, b, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, d, e, d, e, d, d, d, e, e, d, e, d, e, e, d, e, d, e, e, e, e, e, e, e, e, e, e, e, e, e, e
6 in relation to exhaustion, you believe that it is possible to select which of the following drugs, either single or combined (abcd) d, fish liver paste a, cassiterite outlay b, vitamin c, oral administration c, water melon spray 3 and the following, are subject to double-locked exclusive storage (a, c, d), medical toxics a, narcotic drugs b, type ii psychopharmaceuticals c, psychopharmaceutical drugs d4 or less, should be tested or approved in accordance with the regulations of the department of state's drug surveillance and governance department; testing is not allowed for sale or import; (abcd) a, vaccine b, blood products c, external diagnostics for blood source screening d, and other biological products under the state department's medicines supervision and governance department should be returned to the correct options for drug governance (abd):
A, relocation of premises b, increase the size of the warehouse c, chemist adjusts the package d, sub-modification of 7 drugs, labels may not contain (abd): a, through the national gmp recognition b, the chinese medicine strain c, the patent type and patent number d, the national basic health insurance catalogue 8 and the information to be requested for the first-camper review (abc): a, one-certificate b, certificate c, certificate d, certificate of tax registration 9, most sensitive to the following factors (abc):
8 c, temperature d, humidity 10, pharmaceutical products of the following circumstances are counterfeit medicines (bc) a, those that are beyond the validity of b, spoiled c, those that do not have an approved number d, those that do not have a production lot number, iii, brief answers (15 per item, 30 per cent),1 and those of the first enterprise
